| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $3.75 | $3.72 | $4.15 | $3.19 | $2.13 | $3.36 | $3.09 | $0.35 |
| EPS (Diluted) | $3.73 | $3.71 | — | — | — | — | — | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.4B | $2.4B | $2.5B | $2.8B | $2.6B | $1.7B | $1.6B | $1.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.1B | $0.2B | $0.7B | $0.4B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | $2.1B | $2.1B | $2.3B | $2.5B | $2.3B | $1.5B | $1.5B | $1.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.3B | $0.3B | $0.2B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Investing Cash Flow | $0.0B | $0.0B | $-0.3B | $0.1B | $-0.1B | $0.0B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.1B | $-0.2B | $-0.2B | $0.2B | $0.4B | $0.0B | $0.0B | $0.1B |